Vertex Pharmaceuticals Inc (VRTX)

Current ratio

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Total current assets	US$ in thousands	9,596,400	9,804,100	8,941,600	13,288,700	14,144,200	14,695,800	13,872,900	12,965,700	13,234,800	12,271,000	11,503,500	10,361,300	9,560,600	8,852,540	8,457,510	8,539,310	8,133,400	7,458,460	6,694,320	5,446,400
Total current liabilities	US$ in thousands	3,564,600	3,973,100	3,547,200	3,795,900	3,547,400	3,599,400	3,352,100	3,026,200	2,742,100	2,609,300	2,556,200	2,180,200	2,142,000	1,914,260	1,836,450	1,944,050	1,877,500	2,004,030	1,798,640	1,538,750
Current ratio		2.69	2.47	2.52	3.50	3.99	4.08	4.14	4.28	4.83	4.70	4.50	4.75	4.46	4.62	4.61	4.39	4.33	3.72	3.72	3.54

December 31, 2024 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $9,596,400K ÷ $3,564,600K
= 2.69

The current ratio of Vertex Pharmaceuticals Inc has been showing a generally positive trend over the past few years, indicating strong liquidity and the ability to meet short-term obligations.

Starting at 3.54 in March 2020, the ratio increased steadily to reach 4.83 by December 2022, reflecting an improvement in the company's short-term financial position. However, there was a slight decline in the ratio to 3.99 by December 2023 and a more significant decrease to 2.69 by December 2024.

While the ratio remains above 1, which indicates the company has more current assets than current liabilities, the decreasing trend in recent periods suggests a potential concern for liquidity management. It would be advisable for Vertex Pharmaceuticals Inc to closely monitor its current assets and liabilities to ensure continued financial stability.